TETI: Gradual Egg-tolerance Induction in Hen's Egg Allergic Children

Sponsor
Dominque Bullens (Other)
Overall Status
Active, not recruiting
CT.gov ID
NCT02487420
Collaborator
Jessa Hospital (Other), Algemeen Ziekenhuis Maria Middelares (Other), Imelda Hospital, Bonheiden (Other), AZ Sint-Jan AV (Other)
86
6
2
81
14.3
0.2

Study Details

Study Description

Brief Summary

  1. The investigators here want to test the hypothesis that a total period of 18 months of gradual open introduction of a certain egg product with regard to full egg tolerance induction is not inferior when compared to a total period of 30 months gradual open introduction of a certain egg product (see steps for the specific egg products) after tolerance for baked egg has been obtained.

  2. The investigators also want to define step-specific 'tolerance-failures' and study the relevance of specific IgE to specific egg components to predict failures at each step.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: shorter or longer period of specific dietary restrictions
N/A

Detailed Description

  1. The investigators here want to test the hypothesis that a total period of 18 months of gradual open introduction of a certain egg product with regard to full egg tolerance induction is not inferior when compared to a total period of 30 months gradual open introduction of a certain egg product (see steps for the specific egg products) after tolerance to baked egg has been obtained.

  2. The investigators also want to define step-specific 'tolerance-failures' and study the relevance of specific IgE to specific egg components to predict failures at each step.

Step 1: open baked egg test passed (either at home or in the hospital): this is routine clinical practice; afterwards daily intake of increasing amounts of heated egg (amounts to be noted in diary)

Step 2: open provocation test at home with hard-boiled egg, both hen's egg white and yolk, passed; afterwards weekly intake of either hard-boiled egg white or yolk or both (amounts and days to be noted in diary)

Step 3: open provocation test at home with waffles, omelet, pan cake or scrambled egg passed; afterwards weekly or two-weekly intake of one of these specific preparation forms or of the previous preparation forms (amounts, days and preparation to be noted in diary)

Step 4: open provocation test at home with fried or poached egg or softly boiled egg with liquid yolk; afterwards regular intake of one of these preparation forms or one of the prior steps (amounts, days and preparation to be noted in diary)

Step 5: open provocation test at home with raw egg: eg. In chocolate mousse; mayonnaise or tiramisu; afterwards unlimited intake of all egg containing preparation forms (for 3 months in both groups to be noted in the diary)

If tolerance to a certain step is not yet present (this is: if any reaction occurred during the months registered between two steps), the next step will be postponed. The number of failures (any reaction in relation to egg ingestion), the type of reaction and the additional time period necessary before the next step can be taken, will be recorded. After each time period, the investigators will measure specific IgE to hen's egg white and to Gal d 1, as standard clinical practice.

Study Design

Study Type:
Interventional
Actual Enrollment :
86 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Other
Official Title:
Trapsgewijze Ei-tolerantie-inductie Bij Kippenei-allergische Kinderen (TETI Studie)
Actual Study Start Date :
Jul 1, 2015
Actual Primary Completion Date :
May 1, 2021
Anticipated Study Completion Date :
Apr 1, 2022

Arms and Interventions

Arm Intervention/Treatment
Other: Arm 18m

arm 18m: 6 months between step 1 and step 2; 6 months between step 2 and step 3, 3 months between all other steps step by step gradual introduction of egg containing food products during 18 months, unless next step can not be taken

Behavioral: shorter or longer period of specific dietary restrictions
step by step gradual introduction of egg containing food products

Other: arm 30 m

arm 30m: 9 months between step 1 and step 2; 9 months between step 2 and step 3, 6 months between all other steps step by step gradual introduction of egg containing food products during 30 months, unless next step can not be taken

Behavioral: shorter or longer period of specific dietary restrictions
step by step gradual introduction of egg containing food products

Outcome Measures

Primary Outcome Measures

  1. time to complete egg tolerance [18 to 30 months]

    raw egg tolerance (eg in chocolate mousse)

Secondary Outcome Measures

  1. Measurement of specific IgE to egg white components to predict complete egg tolerance [18 to 30 months]

Eligibility Criteria

Criteria

Ages Eligible for Study:
12 Months to 18 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  1. Children (1-18y) had or have a clinical diagnosis of IgE mediated hen's egg allergy based on positive history as well as skin prick testing and/or specific IgE detection by CAPtest in an allergy clinic

  2. Children are at least 12 months old before introduction of heated egg is considered

  3. Children did not suffer from a moderate-to-severe anaphylaxis due to egg-ingestion at presentation

  4. Children have specific IgE levels to Gal d 1 below 1.2 kU/mL or passed cake provocation test -

Exclusion Criteria:
  1. Children had a moderate-to severe anaphylaxis due to egg ingestion

  2. Children are younger than 12 months old at the moment of passing heated egg open provocation test

  3. Parents are not able or not willing to test a certain step in the tolerance induction at home -

Contacts and Locations

Locations

Site City State Country Postal Code
1 University Hospital of Leuven Leuven Vlaams-Brabant Belgium 3000
2 Imelda Hospital, Bonheiden Bonheiden Belgium
3 Sint-Jan Brugge Belgium 8000
4 Algemeen Ziekenhuis Maria Middelares Ghent Belgium
5 Jessa Hospital Hasselt Belgium
6 Sint-Jan Oostende Belgium 8400

Sponsors and Collaborators

  • Dominque Bullens
  • Jessa Hospital
  • Algemeen Ziekenhuis Maria Middelares
  • Imelda Hospital, Bonheiden
  • AZ Sint-Jan AV

Investigators

  • Principal Investigator: Dominique MA Bullens, MD, PhD, UZ Leuven

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Dominque Bullens, MD, PhD, Universitaire Ziekenhuizen Leuven
ClinicalTrials.gov Identifier:
NCT02487420
Other Study ID Numbers:
  • S57588
First Posted:
Jul 1, 2015
Last Update Posted:
Nov 5, 2021
Last Verified:
Nov 1, 2021
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Nov 5, 2021